Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU2013260732B2 - Methods and compositions for live attenuated viruses - Google Patents
[go: Go Back, main page]

AU2013260732B2 - Methods and compositions for live attenuated viruses - Google Patents

Methods and compositions for live attenuated viruses

Info

Publication number
AU2013260732B2
AU2013260732B2 AU2013260732A AU2013260732A AU2013260732B2 AU 2013260732 B2 AU2013260732 B2 AU 2013260732B2 AU 2013260732 A AU2013260732 A AU 2013260732A AU 2013260732 A AU2013260732 A AU 2013260732A AU 2013260732 B2 AU2013260732 B2 AU 2013260732B2
Authority
AU
Australia
Prior art keywords
compositions
methods
live attenuated
attenuated viruses
viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013260732A
Other versions
AU2013260732A1 (en
Inventor
Jorge E. Osorio
Dan T. Stinchcomb
O'neil Wiggan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Vaccines Inc
Original Assignee
Takeda Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008279576A external-priority patent/AU2008279576C1/en
Application filed by Takeda Vaccines Inc filed Critical Takeda Vaccines Inc
Priority to AU2013260732A priority Critical patent/AU2013260732B2/en
Publication of AU2013260732A1 publication Critical patent/AU2013260732A1/en
Assigned to TAKEDA VACCINES, INC. reassignment TAKEDA VACCINES, INC. Request for Assignment Assignors: INVIRAGEN, INC.
Application granted granted Critical
Publication of AU2013260732B2 publication Critical patent/AU2013260732B2/en
Priority to AU2016213859A priority patent/AU2016213859B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013260732A 2007-04-06 2013-11-22 Methods and compositions for live attenuated viruses Active AU2013260732B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2013260732A AU2013260732B2 (en) 2007-04-06 2013-11-22 Methods and compositions for live attenuated viruses
AU2016213859A AU2016213859B2 (en) 2007-04-06 2016-08-12 Methods and compositions for live attenuated viruses

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/910,579 2007-04-06
AU2008279576A AU2008279576C1 (en) 2007-04-06 2008-04-04 Methods and compositions for live attenuated viruses
AU2013260732A AU2013260732B2 (en) 2007-04-06 2013-11-22 Methods and compositions for live attenuated viruses

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2008279576A Division AU2008279576C1 (en) 2007-04-06 2008-04-04 Methods and compositions for live attenuated viruses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016213859A Division AU2016213859B2 (en) 2007-04-06 2016-08-12 Methods and compositions for live attenuated viruses

Publications (2)

Publication Number Publication Date
AU2013260732A1 AU2013260732A1 (en) 2013-12-12
AU2013260732B2 true AU2013260732B2 (en) 2016-05-12

Family

ID=

Similar Documents

Publication Publication Date Title
ZA201400725B (en) Methods and compositions for live attenuated viruses
EP3284772B8 (en) Thioethers, methods for their preparation, and compositions including such thioethers
EP2475632A4 (en) Monochlorotrifluoropropene compounds and compositions and methods using same
EP2483362A4 (en) Fluoropropene compounds and compositions and methods using same
WO2011056650A9 (en) Methods and compositions for treating and preventing viral infections
WO2010123759A9 (en) Compositions and methods for treating burns
ZA201001300B (en) Antigen-asjuvant compositions and methods
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
GB0721291D0 (en) Methods and compositions
EP2294199A4 (en) Compositions and methods for improving plants
GB0719526D0 (en) Compositions and methods
WO2011057220A9 (en) Compositions and methods for treating lymphoma
ZA201101520B (en) Phenanthrenone compounds,compositions and methods
AU2013260732B2 (en) Methods and compositions for live attenuated viruses
AU2014200650C1 (en) Anti-CXCR1 compositions and methods
HK1146525A (en) Compositions and methods for treating purpura
AU2008904402A0 (en) Methods and compositions
AU2008903953A0 (en) Methods and compositions
AU2007900834A0 (en) Methods and compositions
AU2007904579A0 (en) Methods and compositions
HK1147959A (en) Cleaning compositions and methods
AU2008905185A0 (en) Methods and compositions for preparing hormone-depleted surem
AU2007904934A0 (en) Methods and compositions for treating hormonal condition
HK1123731A (en) Methods and compositions for treating conditions
HK1148693A (en) Compositions and devices